item1.txt
On July 1, 2018, the Company adopted Topic 606 and related amendments (ASU 2015-14, Deferral of the Effective Date; ASU 2016-08, Principal versus Agent Considerations; ASU 2016-10, Identifying Performance Obligations and Licensing, ASU 2016-12, Narrow-Scope Improvements and Practical Expedients and ASU 2016-20, Technical Corrections and Improvements to Topic 606, Revenue from Contracts with Customers) using the modified retrospective method applied to all contracts that are not completed at the date of initial application (i.e., July 1, 2018).
•The Company does not disclose the value of unsatisfied performance obligations for (i) contracts with an original expected length of one year or less and (ii) contracts for which the Company recognizes revenue at the amount to which we have the right to invoice for services performed.
•The Company has elected to exclude sales, use, value added, and some excise taxes, if applicable, from the measurement of the transaction price.
In determining the transaction price, the Company evaluates whether the price is subject to refund or adjustment to determine the net consideration that is expected to be entitled.
The Company elected the practical expedient to not disclose the value of unsatisfied performance obligations for (i) contracts with an original expected length of one year or less and (ii) contracts for which we recognize revenue at the amount to which we have the right to invoice for services performed.
Accounts receivable related to consigned inventory is recognized when the customer takes title to such inventory from its consigned location, at which point inventory is relieved, title transfers, and the Company has a legally enforceable right to collection under the terms of the agreement with the related customers.
Customers are generally required to pay for products and services within the Company’s standard terms, which is net 30 days from the date of invoice.
The Company does not have any significant financing components greater than one year.
The Company’s Level 2 assets and liabilities consist of U.S. Treasury securities, agency securities, corporate debt securities, certificates of deposit, commercial paper and foreign currency forward contracts that are valued using quoted market prices or are determined using a yield curve model based on current market rates.
The Company's Level 3 assets and liabilities consist of acquisition related contingent consideration liabilities.
During the three months ended September 29, 2018 and the year ended June 30, 2018, there were no transfers in or out of Level 3 from other levels in the fair value hierarchy.
There were no assets or liabilities measured at fair value on a non-recurring basis as of September 29, 2018 and June 30, 2018 other than impairments of long-lived assets.
For the three months ended September 29, 2018, the Company did not record any impairment of long-lived assets.
For the fiscal year ended June 30, 2018, the Company recorded $0.9 million in impairment of long-lived assets in the Company's Consolidated Statements of Income.
In the three months ended September 29, 2018 and June 30, 2018, the Company did not recognize any impairment charges on short-term investments.
The Company invests in various financial instruments including U.S. Treasury securities, corporate debt securities, commercial paper, and certificates of deposit which include instruments issued or managed by industrial, financial, and utility institutions and U.S. Treasury securities which include U.S. government Treasury bills and Treasury notes.
The Company incurs expenditures denominated in non-U.S. currencies, primarily the Philippine Peso and the Thai Baht associated with the Company's manufacturing activities in the Philippines and Thailand, respectively, and the European Euro, Indian Rupee, Japanese Yen, Taiwan New Dollar, South Korean Won, Chinese Yuan and Canadian Dollar, expenditures for sales offices and research and development activities undertaken outside of the U.S. The Company has established a program that primarily utilizes foreign currency forward contracts to offset the risks associated with the effects of certain foreign currency exposures.
As of September 29, 2018 and June 30, 2018, the notional amounts of the forward contracts the Company held to purchase international currencies were $41.8 million and $49.7 million, respectively, and the notional amounts of forward contracts the Company held to sell international currencies were $0.7 million and $1.2 million, respectively.


item2.txt
Based on this definition, our most critical accounting policies include revenue recognition, which impacts the recording of net revenues; valuation of inventories, which impacts costs of goods sold and gross margins; the assessment of recoverability of long-lived assets, which impacts impairment of long-lived assets; assessment of recoverability of intangible assets and goodwill, which impacts impairment of goodwill and intangible assets; accounting for income taxes, which impacts the income tax provision; and assessment of litigation and contingencies, which impacts charges recorded in cost of goods sold, selling, general and administrative expenses and income taxes.
Net revenues were $638.5 million and $575.7 million for the three months ended September 29, 2018 and September 23, 2017, respectively.
During the three months ended September 29, 2018 and September 23, 2017, approximately 89% and 89% of net revenues, respectively, were derived from customers outside of the United States.
The impact of changes in foreign exchange rates on our revenue and results of operations for the three months ended September 29, 2018 and September 23, 2017 was immaterial.
Our gross margin percentages were 67.4% and 64.9% for the three months ended September 29, 2018 and September 23, 2017, respectively.
Research and development expenses were $112.7 million and $108.6 million for the three months ended September 29, 2018 and September 23, 2017, respectively, which represented 17.7% and 18.9% of net revenues for each respective period.
Selling, general and administrative expenses were $81.5 million and $73.7 million for the three months ended September 29, 2018 and September 23, 2017, respectively, which represented 12.8% and 12.8% of net revenues for each respective period.
Severance and restructuring expenses were $1.0 million and $5.4 million for the three months ended September 29, 2018 and September 23, 2017, respectively, which represented 0.2% and 0.9% of net revenues for each respective period.


item4.txt
Our management, with the participation of our chief executive officer (“CEO”) and our chief financial officer (“CFO”), evaluated the effectiveness of our disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934 (the “Exchange Act”) as of September 29, 2018.
31.1Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) and 15d-14(a) of the Securities Exchange Act


part2.txt
In the fiscal quarter ended September 29, 2018, the Company repurchased approximately 1.9 million shares of its common stock for approximately $112.5 million.
As of September 29, 2018, the Company had remaining authorization of $505.9 million for future share repurchases.


